
The global market for Targeted Sequencing and Resequencing was valued at US$ 47.6 million in the year 2024 and is projected to reach a revised size of US$ 60.8 million by 2031, growing at a CAGR of 3.6% during the forecast period.
The market trend for targeted sequencing and resequencing is experiencing significant growth. This can be attributed to several factors:Advancements in sequencing technologies: The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has revolutionized the field of genomics. These technologies enable cost-effective and rapid sequencing of DNA and RNA samples. Targeted sequencing and resequencing techniques, which focus on specific regions of the genome or specific genetic variants, have become increasingly popular due to their efficiency and affordability.
This report aims to provide a comprehensive presentation of the global market for Targeted Sequencing and Resequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Sequencing and Resequencing.
The Targeted Sequencing and Resequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Sequencing and Resequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Sequencing and Resequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
DNASTAR
PacBio
Bio-Rad Laboratories
Integrated DNA Technologies
Perkin Elmer
RainDance Technologies
PierianDx
BGI
Genomatix GmbH
Macrogen
GATC Biotech Ag
Oxford Nanopore Technologies
QIAGEN
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Segment by Application
Clinical Application
Plant and Animal Sciences
Drug Development
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Sequencing and Resequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Sequencing and Resequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA-based Targeted Sequencing
1.2.3 RNA-based Targeted Sequencing
1.3 Market by Application
1.3.1 Global Targeted Sequencing and Resequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Application
1.3.3 Plant and Animal Sciences
1.3.4 Drug Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Sequencing and Resequencing Market Perspective (2020-2031)
2.2 Global Targeted Sequencing and Resequencing Growth Trends by Region
2.2.1 Global Targeted Sequencing and Resequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Sequencing and Resequencing Historic Market Size by Region (2020-2025)
2.2.3 Targeted Sequencing and Resequencing Forecasted Market Size by Region (2026-2031)
2.3 Targeted Sequencing and Resequencing Market Dynamics
2.3.1 Targeted Sequencing and Resequencing Industry Trends
2.3.2 Targeted Sequencing and Resequencing Market Drivers
2.3.3 Targeted Sequencing and Resequencing Market Challenges
2.3.4 Targeted Sequencing and Resequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Sequencing and Resequencing Players by Revenue
3.1.1 Global Top Targeted Sequencing and Resequencing Players by Revenue (2020-2025)
3.1.2 Global Targeted Sequencing and Resequencing Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Sequencing and Resequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Sequencing and Resequencing Revenue
3.4 Global Targeted Sequencing and Resequencing Market Concentration Ratio
3.4.1 Global Targeted Sequencing and Resequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Sequencing and Resequencing Revenue in 2024
3.5 Global Key Players of Targeted Sequencing and Resequencing Head office and Area Served
3.6 Global Key Players of Targeted Sequencing and Resequencing, Product and Application
3.7 Global Key Players of Targeted Sequencing and Resequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Sequencing and Resequencing Breakdown Data by Type
4.1 Global Targeted Sequencing and Resequencing Historic Market Size by Type (2020-2025)
4.2 Global Targeted Sequencing and Resequencing Forecasted Market Size by Type (2026-2031)
5 Targeted Sequencing and Resequencing Breakdown Data by Application
5.1 Global Targeted Sequencing and Resequencing Historic Market Size by Application (2020-2025)
5.2 Global Targeted Sequencing and Resequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Sequencing and Resequencing Market Size (2020-2031)
6.2 North America Targeted Sequencing and Resequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Sequencing and Resequencing Market Size by Country (2020-2025)
6.4 North America Targeted Sequencing and Resequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Sequencing and Resequencing Market Size (2020-2031)
7.2 Europe Targeted Sequencing and Resequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Sequencing and Resequencing Market Size by Country (2020-2025)
7.4 Europe Targeted Sequencing and Resequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Sequencing and Resequencing Market Size (2020-2031)
8.2 Asia-Pacific Targeted Sequencing and Resequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Sequencing and Resequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Sequencing and Resequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Sequencing and Resequencing Market Size (2020-2031)
9.2 Latin America Targeted Sequencing and Resequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Sequencing and Resequencing Market Size by Country (2020-2025)
9.4 Latin America Targeted Sequencing and Resequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Sequencing and Resequencing Market Size (2020-2031)
10.2 Middle East & Africa Targeted Sequencing and Resequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Sequencing and Resequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Sequencing and Resequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Targeted Sequencing and Resequencing Introduction
11.1.4 Agilent Technologies Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Targeted Sequencing and Resequencing Introduction
11.2.4 Illumina Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Targeted Sequencing and Resequencing Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Targeted Sequencing and Resequencing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 DNASTAR
11.5.1 DNASTAR Company Details
11.5.2 DNASTAR Business Overview
11.5.3 DNASTAR Targeted Sequencing and Resequencing Introduction
11.5.4 DNASTAR Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.5.5 DNASTAR Recent Development
11.6 PacBio
11.6.1 PacBio Company Details
11.6.2 PacBio Business Overview
11.6.3 PacBio Targeted Sequencing and Resequencing Introduction
11.6.4 PacBio Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.6.5 PacBio Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Targeted Sequencing and Resequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Integrated DNA Technologies
11.8.1 Integrated DNA Technologies Company Details
11.8.2 Integrated DNA Technologies Business Overview
11.8.3 Integrated DNA Technologies Targeted Sequencing and Resequencing Introduction
11.8.4 Integrated DNA Technologies Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.8.5 Integrated DNA Technologies Recent Development
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Details
11.9.2 Perkin Elmer Business Overview
11.9.3 Perkin Elmer Targeted Sequencing and Resequencing Introduction
11.9.4 Perkin Elmer Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.9.5 Perkin Elmer Recent Development
11.10 RainDance Technologies
11.10.1 RainDance Technologies Company Details
11.10.2 RainDance Technologies Business Overview
11.10.3 RainDance Technologies Targeted Sequencing and Resequencing Introduction
11.10.4 RainDance Technologies Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.10.5 RainDance Technologies Recent Development
11.11 PierianDx
11.11.1 PierianDx Company Details
11.11.2 PierianDx Business Overview
11.11.3 PierianDx Targeted Sequencing and Resequencing Introduction
11.11.4 PierianDx Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.11.5 PierianDx Recent Development
11.12 BGI
11.12.1 BGI Company Details
11.12.2 BGI Business Overview
11.12.3 BGI Targeted Sequencing and Resequencing Introduction
11.12.4 BGI Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.12.5 BGI Recent Development
11.13 Genomatix GmbH
11.13.1 Genomatix GmbH Company Details
11.13.2 Genomatix GmbH Business Overview
11.13.3 Genomatix GmbH Targeted Sequencing and Resequencing Introduction
11.13.4 Genomatix GmbH Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.13.5 Genomatix GmbH Recent Development
11.14 Macrogen
11.14.1 Macrogen Company Details
11.14.2 Macrogen Business Overview
11.14.3 Macrogen Targeted Sequencing and Resequencing Introduction
11.14.4 Macrogen Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.14.5 Macrogen Recent Development
11.15 GATC Biotech Ag
11.15.1 GATC Biotech Ag Company Details
11.15.2 GATC Biotech Ag Business Overview
11.15.3 GATC Biotech Ag Targeted Sequencing and Resequencing Introduction
11.15.4 GATC Biotech Ag Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.15.5 GATC Biotech Ag Recent Development
11.16 Oxford Nanopore Technologies
11.16.1 Oxford Nanopore Technologies Company Details
11.16.2 Oxford Nanopore Technologies Business Overview
11.16.3 Oxford Nanopore Technologies Targeted Sequencing and Resequencing Introduction
11.16.4 Oxford Nanopore Technologies Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.16.5 Oxford Nanopore Technologies Recent Development
11.17 QIAGEN
11.17.1 QIAGEN Company Details
11.17.2 QIAGEN Business Overview
11.17.3 QIAGEN Targeted Sequencing and Resequencing Introduction
11.17.4 QIAGEN Revenue in Targeted Sequencing and Resequencing Business (2020-2025)
11.17.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Agilent Technologies
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
DNASTAR
PacBio
Bio-Rad Laboratories
Integrated DNA Technologies
Perkin Elmer
RainDance Technologies
PierianDx
BGI
Genomatix GmbH
Macrogen
GATC Biotech Ag
Oxford Nanopore Technologies
QIAGEN
Ìý
Ìý
*If Applicable.
